0.8(top 50%)
impact factor
217(top 50%)
papers
2.5K(top 50%)
citations
25(top 20%)
h-index
1.1(top 50%)
impact factor
259
all documents
2.6K
doc citations
40(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic riskCountry Review Ukraine2006135
2Reassessing treatment of acute heart failure syndromes: the ADHERE RegistryCountry Review Ukraine2005109
3The role of HDL-cholesterol in preventing atherosclerotic diseaseCountry Review Ukraine200588
4What is the relationship between risk factor reduction and degree of weight loss?Country Review Ukraine200581
5The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunctionCountry Review Ukraine200667
6Introduction to the metabolic syndromeCountry Review Ukraine200560
7Bleeding and management of bleedingCountry Review Ukraine200660
8The SCOUT study: risk-benefit profile of sibutramine in overweight high-risk cardiovascular patientsCountry Review Ukraine200557
9Testing antiplatelet therapyCountry Review Ukraine200846
10Premature withdrawal and alternative therapies to dual oral antiplatelet therapyCountry Review Ukraine200643
11Epidemiology, treatment, and guidelines for the treatment of heart failure in EuropeCountry Review Ukraine200541
12Inflammatory response post-myocardial infarction and reperfusion: a new therapeutic target?Country Review Ukraine200541
13Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolismCountry Review Ukraine200639
14Model of chronic adaptation: right ventricular function in Eisenmenger syndromeCountry Review Ukraine200739
15Heart rate: an independent risk factor in cardiovascular diseaseCountry Review Ukraine200738
16From individual risk factors and the metabolic syndrome to global cardiometabolic riskCountry Review Ukraine200838
17Reviewing the reality: why we need to changeCountry Review Ukraine200535
18Blood pressure is the most important cause of death and disability in the worldCountry Review Ukraine200735
19Resistance to antiplatelet drugsCountry Review Ukraine200634
20Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm AssociationCountry Review Ukraine200734
21Epidemiology of low HDL-cholesterol: results of studies and surveysCountry Review Ukraine200631
22Intra-abdominal adiposity, abdominal obesity, and cardiometabolic riskCountry Review Ukraine200830
23Angiotensin-converting enzyme inhibition: a landmark advance in treatment for cardiovascular diseasesCountry Review Ukraine200728
24Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetesCountry Review Ukraine200627
25How should we assess right ventricular function in 2008?Country Review Ukraine200727
26The changing epidemiology of non-valvular atrial fibrillation: the role of novel risk factorsCountry Review Ukraine200525
27The follow-up of cardiac devices: what to expect for the future?Country Review Ukraine200725
28Aetiology and consequences of the metabolic syndromeCountry Review Ukraine200524
29Right ventricular function in pulmonary hypertension: physiological conceptsCountry Review Ukraine200724
30Evolution of pacing for bradycardias: sensorsCountry Review Ukraine200723
31Evolution of pacing for bradycardia: AutocaptureCountry Review Ukraine200722
32Low-gradient ‘severe’ aortic stenosis with preserved ejection fraction: new entity, or discrepant definitions?Country Review Ukraine200822
33Clinical application of the natriuretic peptides in heart failureCountry Review Ukraine200621
34Hypertension, society, and public policyCountry Review Ukraine200721
35Pressure overload-induced right ventricular dysfunction and remodelling in experimental pulmonary hypertension: the right heart revisitedCountry Review Ukraine200721
36Pharmacology of thienopyridines: rationale for dual pathway inhibitionCountry Review Ukraine200620
37Dyslipidaemia and global cardiovascular risk: clinical issuesCountry Review Ukraine200620
38The QT interval as it relates to the safety of non-cardiac drugsCountry Review Ukraine200720
39New developments in oral antiplatelet therapyCountry Review Ukraine200720
40A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factorCountry Review Ukraine200820
41Maximizing coronary disease risk reduction using nicotinic acid combined with LDL-lowering therapyCountry Review Ukraine200519
42History of electrical therapy for the heartCountry Review Ukraine200719
43Niaspan®: creating a new concept for raising HDL-cholesterolCountry Review Ukraine200517
44International Day for the Evaluation of Abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countriesCountry Review Ukraine200617
45Beta-blockade in CHF: from contraindication to indicationCountry Review Ukraine200617
46Reducing risk by raising HDL-cholesterol: the evidenceCountry Review Ukraine200617
47When and how to discontinue antiplatelet therapyCountry Review Ukraine200816
48The realities of dyslipidaemia: what do the studies tell us?Country Review Ukraine200515
49Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertensionCountry Review Ukraine200715
50Implantable cardioverter defibrillators: from evidence of trials to clinical practiceCountry Review Ukraine200715